News & Events

Join NETP to hear from Dr. Nanthia Suthana as she discusses Novel neurotechnologies for studying the human brain in the real world.

Wolfgang Pauli Collegiate Professor of Chemical Engineering, Joerg Lahann, has been honored as an American Association for the Advancement of Science (AAAS) fellow. The AAAS fellowship is one of the most distinct honors in the scientific community.

A newly discovered pinwheel structure — self-assembled from pyramid-shaped nanoparticles — may enable unique material properties that could be useful in areas like machine vision, armor, chemical and biological sensing, and more.

Congratulations to James Moon on being named a 2022 winner of the MBioFAR Award, which recognizes exceptional mid-career faculty in the biosciences.

Cancer cells delete DNA when they go to the dark side, so a team of doctors and engineers – led by Deepak Nagrath – targeted the ‘backup plans’ running critical cell functions

Somin Lee and her research group developed a way to reduce trial and error in gene editing by getting a look at the process in real time.

Polyurethane locks in the antimicrobial power of tea tree and cinnamon oils. The new technology from the Tuteja lab could start making public spaces safer within a year.

We are pleased to announce the funding selections for the MNI-BI 2022 Neuroregeneration and Cognition Challenge seed fund competition.

Congratulations to the 2022 BI Innovator Award Recipients. BI Innovator awards recognize members of the BI research community who are active participants in the research, innovation and translational ecosystem at BI and making a difference in our community.

BI welcomes Carl Gordon and Natasha Shervani of OrbiMed as new members of its External Advisory Board.

Sharon Glotzer has received the Vannevar Bush Faculty Fellowship from the U.S. Department of Defense, becoming one of nine distinguished faculty scientists and engineers to receive the award this year.

Lola Eniola-Adefeso is part of an international research team that recently received $7.5 million from the Leducq Foundation for their AntheroGEN project.

Joerg Lahann and Colin Greineder are part of the research team that received funding from the NIH to study a new nanomedicine that crosses the blood-brain barrier, engages the immune system and kills cancer cells may offer hope for treating the most aggressive form of brain cancer, glioblastoma.

A new study from the Schwendeman lab describes one of the first entirely new drug delivery microencapsulation approaches in decades.

Developed in the VanEpps and Kotov labs, a new machine learning model that predicts interactions between nanoparticles and proteins.